How Does a Class Action Lawsuit for Pradaxa Complications Work?
The class action lawyers at Saiontz & Kirk, P.A. are continuing to review new cases for individuals who suffered bleeding problems following use of Pradaxa.
While a settlement was announced in late May 2014, which resolved approximately 4,000 cases pending at that time, a second wave of claims is being pursued on behalf of individuals who were not covered by the settlement or have suffered an injury or wrongful death since that time.
To review whether you or a loved one may be entitled to financial compensation through a Pradaxa class action injury claim, request a free consultation and case evaluation.
Pradaxa MDL vs Class Action Lawsuit
Prior to the 2014 Pradaxa settlement, all cases pending throughout the federal court system were centralized as part of a federal multidistrict litigation, or MDL.
Although the cases were handled similar to how a class action for Pradaxa would proceed, the MDL process is different. Each plaintiff must still establish their claim and an individual settlement or resolution must be reached based on the individual circumstances in each case for any damages from Pradaxa.
Unlike a class action lawsuit, each claim consolidated as part of the Pradaxa MDL must be weighed on it’s own merits, as the problems and complications caused for each individual will be very different. Therefore, the lawsuits cannot proceed through a class representative, as would be the case in class action litigation.
Although Pradaxa was only introduced by Boehringer Ingelheim in October 2010, it has already been linked to thousands of deaths of reports of bleeding problems.
Even after agreeing to settle failure to warn cases, the drug maker continues to provide Pradaxa warnings that fail to adequately inform consumers and the medical community about the severity of these side effects.
As a result, financial compensation may be available through a lawsuit for individuals who have experienced complications from Pradaxa.